Your browser doesn't support javascript.
loading
Phase II trial of celecoxib in combination with paclitaxel and carboplatin in advanced non-small cell lung cancer
Tanaffos. 2007; 6 (1): 37-46
in En | IMEMR | ID: emr-85413
Responsible library: EMRO
Search on Google
Index: IMEMR Main subject: Pyrazoles / Carboplatin / Treatment Outcome / Paclitaxel / Drug Therapy, Combination / Drug-Related Side Effects and Adverse Reactions / Cyclooxygenase 2 Limits: Adult / Aged / Female / Humans / Male Language: En Journal: Tanaffos Year: 2007
Search on Google
Index: IMEMR Main subject: Pyrazoles / Carboplatin / Treatment Outcome / Paclitaxel / Drug Therapy, Combination / Drug-Related Side Effects and Adverse Reactions / Cyclooxygenase 2 Limits: Adult / Aged / Female / Humans / Male Language: En Journal: Tanaffos Year: 2007